FTRE Q1 2025 Earnings — Fortrea Holdings Inc. Revenue & Financial Results | Market Cap Arena

FTREFortrea Holdings Inc.

$851M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$651M-1.6% YoY

Gross Profit

$117M17.9% margin

Operating Income

-$520M-79.9% margin

Net Income

-$563M-86.4% margin

EPS (Diluted)

$-6.30

QoQ Revenue Growth

-6.6%

Cash Flow

Operating Cash Flow

-$124M

Free Cash Flow

-$127M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$3.1B

Total Liabilities

$2.3B

Stockholders' Equity

$859M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$651M	$662M	-1.6%
Gross Profit	$117M	$108M	+8.0%
Operating Income	-$520M	-$37M	-1290.6%
Net Income	-$563M	-$101M	-457.3%

Revenue Segments

Clinical Services Segment

$651M100%

Geographic Segments

North America

$310M48%

Europe

$200M31%

Other Geographical Areas

$142M22%